Events occurring during follow-up after TAVI
| Events | All patients n=123 | Dead n=77 | Alive n=45 |
|---|---|---|---|
| Severe bleeding | 9 | 8 | 1 |
| Ischaemic stroke | 12 (9.8) | 9 (11.7) | 3 (6.5) |
| Haemorrhagic stroke | 4 (3.3) | 4 (5.2) | 0 |
| Infective endocarditis | 3 (2.4) | 3 (3.9) | 0 |
| Pacemaker implantation | 18 (14.6) | 9 (11.7) | 9 (19.6) |
| Rehospitalisation | |||
| All cause | 96 (78) | 70 (90.9) | 26 (56.5) |
| Cardiac | 42 (43.7) | 30 | 12 |
| Non-cardiac | 54 (56.3) | 40 | 14 |
| Death | |||
| All cause | 77 (62.6) | 77 | 0 |
| Cardiac | 25 (32.5) | 25 | |
| Non cardiac | 44 (57.1) | 44 | |
| Unknown | 8 (10.4) | 8 | |
| NYHA III–IV at last follow-up | 40 (32.5) | 28 (37.8) | 12 (26.1) |
Data are presented as n (%).
NYHA, New York Heart Association; TAVI, transcatheter aortic valve implantation.